Search Within

MSK Grad Students

  1. "2021"
Formats
  1. Journal Article (183)
  2. Meeting Abstract (64)
  3. Review (25)
  4. Editorial (8)
  5. Research Letter (5)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. GSK Faculty (210)
  2. Sloan Kettering Institute Postdocs (172)
  3. Department of Medicine (169)
  4. Sloan Kettering Institute Faculty (122)
  5. CTCR Scholars (106)
  6. Master of Science in Clinical and Translational Cancer Research (104)

More Groups

People
  1. Miguel-Angel Perales (34)
  2. Sergio Giralt (33)
  3. Parastoo Dahi (24)
  4. Roni Tamari (23)
  5. Sean Devlin (22)
  6. Craig Sauter (20)

More People

Years
  1. 2021 (289)
Publications
  1. Blood (29)
  2. Nature Communications (14)
  3. Journal of Clinical Oncology (10)
  4. Clinical Cancer Research (9)
  5. Nature (9)
  6. Transplantation and Cellular Therapy (9)

More Publications

Publishers
  1. Nature Publishing Group (49)
  2. American Society of Hematology (34)
  3. Cell Press (32)
  4. American Association for Cancer Research (24)
  5. Elsevier Inc. (20)
  6. Springer (15)

More Publishers

Results (289)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Local control and survival after induction chemotherapy and ablative radiation versus resection for pancreatic ductal adenocarcinoma with vascular involvement
    Journal Article

    Jolissaint, J. S.; Reyngold, M.; Bassmann, J.; Seier, K. P.; Gönen, M.; Varghese, A. M.; Yu, K. H.; Park, W.; O'Reilly, E. M.; Balachandran, V. P.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation
    Journal Article

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
    Advances in Cell and Gene Therapy (2021)

    Fulltext@MSK | Save
  • Highly selective irreversible ITK inhibitor Cpi-818 reduces acute graft-versus host disease
    Meeting Abstract

    Lindner, S.; Lee, N.; Armijo, G. K.; Burgos da Silva, Marina; Herrera, P. S.; Nguyen, C. L.; Dwomoh, E. A.; Ghale, R.; Smith, M.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Post-transplant cyclophosphamide is associated with improved clinical outcomes in HLA-mismatched unrelated donor hematopoietic cell transplantation
    Meeting Abstract

    Jimenez, A. M.; Perales, M. A.; Devlin, S. M.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Beitinjaneh, A.; Brown, S.; Wang, T.; Ponce, D. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Quantitative change in metabolic tumor volume may assist in distinguishing between pseudoprogressors and responders in patients with relapsed/refractory classical Hodgkin lymphoma treated with PD-1 blockade
    Meeting Abstract

    Wills, B.; Michaud, L.; Schöder, H.; Ganesan, N.; Moskowitz, C. H.; Straus, D. J.; Falchi, L.; Matasar, M. J.; Zelenetz, A. D.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study
    Meeting Abstract

    Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Prognostic value of minimal residual disease (MRD) among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation
    Meeting Abstract

    Taranto, E.; Redd, R. A.; Jeter, E.; McHugh, K. M.; Brown, J. R.; Crombie, J. L.; Davids, M. S.; Fisher, D. C.; Freedman, A. S.; Jacobsen, E. D.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Timing and immune status after cellular therapies predict response to COVID-19 vaccines
    Meeting Abstract

    Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures
    Meeting Abstract

    Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Blood (2021)

    Fulltext@MSK | Save